1. Home
  2. SIBN vs ZVRA Comparison

SIBN vs ZVRA Comparison

Compare SIBN & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SI-BONE Inc.

SIBN

SI-BONE Inc.

HOLD

Current Price

$14.66

Market Cap

622.3M

Sector

Health Care

ML Signal

HOLD

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$10.52

Market Cap

653.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIBN
ZVRA
Founded
2008
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
622.3M
653.2M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
SIBN
ZVRA
Price
$14.66
$10.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
5
Target Price
$23.88
$23.00
AVG Volume (30 Days)
765.5K
1.3M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
41.33
159.21
EPS
N/A
0.60
Revenue
$67,301,000.00
$106,470,000.00
Revenue This Year
$16.95
$37.27
Revenue Next Year
$14.93
$53.42
P/E Ratio
N/A
$17.05
Revenue Growth
21.53
350.91
52 Week Low
$11.48
$7.16
52 Week High
$21.89
$13.16

Technical Indicators

Market Signals
Indicator
SIBN
ZVRA
Relative Strength Index (RSI) 58.77 51.08
Support Level $14.42 $8.30
Resistance Level $14.85 $11.07
Average True Range (ATR) 0.81 0.64
MACD 0.22 -0.09
Stochastic Oscillator 91.60 26.10

Price Performance

Historical Comparison
SIBN
ZVRA

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: